Newborn Screening Market - Driver is Expected to Lead Market Growth – Growing at a Compound Annual Growth Rate (CAGR) 8.1% from 2022 to 2028

Newborn Screening
  • Newborn Screening Market

As stated in our extensive report, the Global Newborn Screening Market accounted for USD 729.5 Million in the year 2021. Newborn Screening identifies conditions that can have a long-term impact on a child's health or survival. This screening method consists of tests necessary for early identification, diagnosis, and health management to prevent overall disability and mortality in children. These tests reveal genetic, developmental, and metabolic problems in newborn babies and are conducted shortly after the baby is delivered. For example, before discharge from a hospital or birthing facility, a few drops of blood from the newborn’s heel are tested for specific genetic, endocrine, and metabolic diseases, hearing loss, and fatal congenital heart abnormalities (CCAs).

The COVID-19 pandemic had a detrimental influence on Newborn Screening since most screening centers encountered various issues, with the majority being more affected in the second wave of the pandemic. Due to postal delays & unreliability, as well as flight cancellations and the availability of laboratory equipment & reagents, samples arriving at screening locations were delayed. Laboratory personnel availability was occasionally reduced due to infection, quarantine, or relocation within the healthcare center. Collecting samples at home, second-tier tests, and follow-up were all affected. Social restrictions and public transportation delays exacerbated these problems. Only a few centers were able to maintain the entire operation of their NBS (Newborn Screening) programs.

The increasing neonatal population is driving global Newborn Screening Market growth, increased awareness of the separate specialty for newborns, rapid adoption of minimally & non-invasive Newborn Screening procedures, and favorable health reimbursement. Furthermore, the worldwide Newborn Screening Market is expected to be fueled by the increased prevalence of congenital cardiac diseases and genetic abnormalities among infants. Additionally, government and commercial sector activities and advancements in new technologies are propelling the worldwide Newborn Screening Market forward. On the other hand, a lack of awareness among parents regarding neonatal screening, a scarcity of experienced experts, and the inaccuracy of some tests are significant challenges that could impede the worldwide Newborn Screening Market's growth.

North Americaholds the largest share in theNewborn Screening Marketand is expected to continue this trend in the forecast period, followed by Europe. The availability of screening programs, attractive reimbursement policies, and a strong market player presence are all factors driving growth in the North American Market. However, Asia Pacific is expected to have the most remarkable Compound Annual Growth Rate (CAGR) forecast period. The big infant pool, growing screening rates, and expanding awareness about early diagnosis are all driving growth in this region.

Some of the key players in the Global Newborn Screening Market include- PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Recipe Chemicals+Instruments (Germany) and others.